Study of ENC1018 capsules for moderate-to-severe ulcerative colitis
Part of Digestive system clinical trials.
This trial tests an experimental drug called ENC1018 for people with moderate-to-severe ulcerative colitis who haven't responded well to standard treatments. It aims to see if the drug is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with ulcerative colitis for at least 3 months.
- Your ulcerative colitis is moderate to severe (Mayo score of 6 or higher).
- You have tried at least one standard treatment (like mesalamine, steroids, or biologic drugs) and it didn't work well or you couldn't tolerate it.
- You are willing to keep your current doses of oral mesalamine or steroids stable for 2 weeks before and during the study.
- You do not have other bowel diseases like Crohn's disease, and you have not had surgery for your UC.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental capsule called INT-210 for people with active ulcerative colitis (UC) who haven't improved enough with standard treatments. It aims to see if the drug can help control symptoms and improve the condition.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This trial tests an oral tablet called AC-101 for people with moderate to severe ulcerative colitis. It aims to see if the drug can reduce inflammation in the colon and improve symptoms.
This study tests an investigational oral drug for ulcerative colitis. It is an early-stage trial to check safety and how the drug is processed by the body in both healthy volunteers and patients with active ulcerative colitis.
This study tests an investigational medication called LY4268989 for adults with moderate to severe ulcerative colitis (UC). It's for people who have tried other treatments without success. The goal is to see if the drug can reduce inflammation and improve symptoms.
This study tests an experimental drug called HSK47388 for people with moderate to severe ulcerative colitis who have not had good results from other treatments. The goal is to see if it can reduce inflammation and improve symptoms.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.